Profile
Måns Eskil Barsne is on the board of Ferrosan Medical Devices An and Executive VP-Global Research & Development at Ambu A.
Former positions of Måns Eskil Barsne
Companies | Position | End |
---|---|---|
AMBU A/S | Corporate Officer/Principal | 2023-09-01 |
Ferrosan Medical Devices A/S
Ferrosan Medical Devices A/S Medical SpecialtiesHealth Technology Ferrosan Medical Devices A/S manufactures and distributes consumer health and pharmaceutical products and devices. It produces gelatin-based topical absorbable haemostatic products. The firm's products are surgiflo, which is a a sterile, absorbable porcine gelatin paste intended for haemostatic use by applying to a bleeding surface; surgifoam, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface; and spongostan, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface. The company was founded in May 2010 and is headquartered in Søborg, Denmark. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AMBU A/S | Health Technology |
Private companies | 1 |
---|---|
Ferrosan Medical Devices A/S
Ferrosan Medical Devices A/S Medical SpecialtiesHealth Technology Ferrosan Medical Devices A/S manufactures and distributes consumer health and pharmaceutical products and devices. It produces gelatin-based topical absorbable haemostatic products. The firm's products are surgiflo, which is a a sterile, absorbable porcine gelatin paste intended for haemostatic use by applying to a bleeding surface; surgifoam, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface; and spongostan, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface. The company was founded in May 2010 and is headquartered in Søborg, Denmark. | Health Technology |
- Stock Market
- Insiders
- Måns Eskil Barsne